Azulfidine and Breathing difficulty - a phase IV clinical study of FDA data
Breathing difficulty is found among people who take Azulfidine, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Azulfidine and have Breathing difficulty. It is created by eHealthMe based on reports of 7,219 people who have side effects when taking Azulfidine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
7,219 people reported to have side effects when taking Azulfidine.
Among them, 186 people (2.58%) have Breathing difficulty.
What is Azulfidine?
Azulfidine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 7,319 Azulfidine users for its effectiveness, alternative drugs and more.
What is Breathing difficulty?
Breathing difficulty is found to be associated with 4,614 drugs and 5,672 conditions by eHealthMe.
Number of Azulfidine and Breathing difficulty reports submitted per year:
Time on Azulfidine when people have Breathing difficulty *:
Gender of people who have Breathing difficulty when taking Azulfidine*:
Age of people who have Breathing difficulty when taking Azulfidine *:
Common drugs people take besides Azulfidine *:
Common side effects people have besides Breathing difficulty *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Azulfidine and have Breathing difficulty?Check whether Breathing difficulty is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Azulfidine:
- Azulfidine (7,319 reports)
Breathing difficulty treatments and more:
- Breathing difficulty (530,195 reports)
COVID vaccines that are related to Breathing difficulty:
- Breathing difficulty in Moderna COVID Vaccine
- Breathing difficulty in Pfizer BioNTech Covid Vaccine
- Breathing difficulty in Johnson and Johnson Covid Vaccine
How severe was Breathing difficulty and when was it recovered:
Expand to all the drugs that have ingredients of sulfasalazine:
- Breathing difficulty and drugs with ingredients of sulfasalazine (1,864 reports)
Common drugs associated with Breathing difficulty:
All the drugs that are associated with Breathing difficulty:
- Breathing difficulty (4,614 drugs)
Common conditions associated with Breathing difficulty:
All the conditions that are associated with Breathing difficulty:
- Breathing difficulty (5,672 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sulfasalazine (the active ingredients of Azulfidine) and Azulfidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xeljanz Xr and Brain Neoplasm Malignant - 4 seconds ago
- Prilosec and Posterior Reversible Encephalopathy Syndrome - 5 seconds ago
- Pain Exacerbated and Gout - 5 seconds ago
- Megace and Haemolytic Uraemic Syndrome - 7 seconds ago
- Ampyra and Ketorolac Tromethamine drug interaction - 11 seconds ago